Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE2

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-07

Study Completion Date

2026-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Spine radiosurgery (SRS) utilizes advanced treatment planning with focused x-rays to deliver one to four high dose treatments to the spine to help relieve pain and/or neurologic symptoms. Spine SRS uses special equipment to position the participant and guide the focused beams toward the area to be treated and away from normal tissue.

One of the side effects of spine SRS is the development of vertebral compression fractures, many of which are not painful. The goal of this study is to compare the effects, good and/or bad, of spine SRS given in 1 or 2 treatments. Our main goal is to find out which approach will reduce the chances of developing vertebral compression fractures.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Single Versus Multifraction Salvage Spine Stereotactic Radiosurgery for Previously Irradiated Spinal Metastases

NCT03028337

Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System

RECRUITING PHASE2

Vertebroplasty With Radiation Therapy for Spine Metastatic Cancer Patients With Indeterminate Lesion (SINS Criteria)

NCT05178472

Hematopoietic and Lymphoid Cell Neoplasm Malignant Solid Neoplasm Metastatic Malignant Neoplasm in the Spine

RECRUITING NA

Radiation Therapy Alone Versus Radiation Therapy Plus Radiofrequency Ablation (RFA)/Vertebral Augmentation

NCT04375891

Oncology Spine Metastases

ACTIVE_NOT_RECRUITING NA

Comparing SingLe- Vs Multi-Fraction Spine STereotActic Radiosurgery in Spinal Metastases

NCT06173401

Spinal Metastases

RECRUITING PHASE3

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

NCT00922974

Metastatic Cancer Pain

COMPLETED PHASE2/PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The primary objective of this study is to establish the non-inferiority in vertebral compression fracture (VCF) incidence at 6 months between single-fraction and two-fraction sSRS.

Other objectives are to to evaluate the 12-month impact of single- and two-fraction sSRS on local control (LC), pain control (PC), quality of life (QOL), and toxicity (specifically, pain flare, radiation esophagitis/laryngitis/pharyngitis, and radiation myelitis)

This study is planned as a two-arm randomized phase II trial to establish non-inferiority of single fraction sSRS compared to two-fraction sSRS. Approximately 130 participants will be enrolled in this trial; 65 participants in each arm:

* Group 1: If you are assigned to this group, you will undergo spine radiosurgery in a single (1) session.
* Group 2: If you are assigned to this group, you will undergo spine radiosurgery in two (2) sessions.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spine Metastases Spine Stereotactic Radiosurgery (sSRS)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diagnostic MRI

Intervention Type DEVICE

Planning MRI

Planning MRI: high definition (HD) MRI of the region of interest (1 vertebral level above and below the level(s) being treated)

Intervention Type DEVICE

Simulation CT

Simulation CT is obtained (1.5 mm slice thickness)

Intervention Type OTHER

QOL assessment

Intervention Type OTHER

Brief pain inventory (BPI)

Brief pain inventory (BPI), including narcotic assessment

Intervention Type OTHER

sSRS in 1 fraction

sSRS 18 Gy in 1 fraction

Intervention Type RADIATION

sSRS in 2 fraction

sSRS 24 Gy in 2 fractions to be delivered either on consecutive days or one day apart.

Intervention Type RADIATION

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Karnofsky Performance Status (KPS) ≥ 70
* RPA class 1 (KPS \>70 AND controlled systemic disease) or RPA Class 2 (KPS \>70, uncontrolled systemic disease OR KPS ≤70, age ≥54, no visceral metastases)44 (see Appendix II)
* Vertebral metastases from C3 to L5 based on bone scan, CT, PET, or MRI.
* Vertebral metastases must be (1) solitary, (2) at two contiguous levels, or (3) a maximum of three separate sites, with a maximum of two contiguous levels.
* Radioresistant metastases are permitted (including sarcomas, melanomas, and renal cell carcinomas).
* Patients with epidural disease are permitted so long as there is no cord compression.
* Paraspinal extension is permitted, so long as the paraspinal component is ≤5 cm
* Multiple small metastatic lesions (\<20% vertebral body involvement) of no clinical correlate are permitted, and not included in the irradiated segments as per RTOG 0631
* History and physical within four weeks of registration.
* Negative pregnancy test within four weeks of registration for women of childbearing potential.
* Diagnostic spine MRI with and without contrast within four weeks of registration
* Neurological exam within four weeks of registration to rule out rapid neurological decline. Mild to moderate neurological deficits are acceptable, as long as distance between lesion and spinal cord is ≥3 mm
* Patients may have prior EBRT at the index site.
* Informed consent of the participant.

Exclusion Criteria

* Lesions at C1-2 or S1-Coccyx.
* Hematologic malignancies including lymphoma and myeloma.
* Multiple primary cancers.
* Primary neoplasms of the spine
* Prior corpectomy, kyphoplasty/vertebroplasty, or instrumentation at the site of planned sSRS.
* Spinal cord compression.
* Paraspinal mass \>5 cm.
* Patients with rapid neurologic decline.
* Bony retropulsion resulting in neurologic deficit.
* Patients with contraindications to MRI.
* Patients allergic to intravenous contrast for MRI or CT.
* Patients with emergent spinal cord compression.
* Patients with mechanical instability of the spine.
* Patients with active connective tissue disease.
* Patients who previously underwent sSRS to the vertebrae of interest.
* Patients with diffuse or multilevel metastatic spinal disease with \>20% involvement of vertebral bodies, defined as involvement of \>5 vertebral levels.
* Inability to participate in study activities due to physical or mental limitations.
* Inability or unwillingness to return for all required follow-up visits and imaging.
* Inability to deliver sSRS, either 18 Gy in one fraction, or 24 Gy in two fractions.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No